FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway

Nature Structural and Molecular Biology

Volumn 15, Issue 11, 2008, Pages 1138-1146

  Ishiai, Masamichi ^a   Kitao, Hiroyuki ^a,b,f   Smogorzewska, Agata ^c,d   Tomida, Junya ^a   Kinomura, Aiko ^b   Uchida, Emi ^a   Saberi, Alihossein ^a,g   Kinoshita, Eiji ^e   Kinoshita Kikuta, Emiko ^e   Koike, Tohru ^e   Tashiro, Satoshi ^b   Elledge, Stephen J ^c   Takata, Minoru ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HIROSHIMA UNIVERSITY   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g Research Institute for Infectious Diseases of Digestive System   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP I PROTEIN; FANCONI ANEMIA PATHWAY; FANCONI ANEMIA PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL KILLING; CHICKEN; CHROMOSOME BREAKAGE; DNA BINDING MOTIF; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GENE SWITCHING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

ANIMALS; CAFFEINE; CELL CYCLE PROTEINS; CELL LINE; CHICKENS; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; MOLECULAR MIMICRY; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 55549137026     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.1504     Document Type: Article

References (38)

1. Hoeijmakers, J.H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
2. Nijnik, A. et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447, 686-690 (2007).
3. Ito, K. et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431, 997-1002 (2004).
4. Rossi, D.J. et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447, 725-729 (2007).
5. D'Andrea, A.D. & Grompe, M. The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3, 23-34 (2003).
6. Wang, W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8, 735-748 (2007).
7. Smogorzewska, A. et al. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129, 289-301 (2007).
8. Sims, A.E. et al. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14, 564-567 (2007).
9. Dorsman, J.C. et al. Identification of the Fanconi anemia complementation group I gene, FANCI. Cell. Oncol. 29, 211-218 (2007).
10. Andreassen, P.R., D'Andrea, A.D. & Taniguchi, T. ATR couples FANCD2 mono-ubiquitination to the DNA-damage response. Genes Dev. 18, 1958-1963 (2004).
11. Machida, Y.J. et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23, 589-596 (2006).
12. Ciccia, A. et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell 25, 331-343 (2007).
13. Ling, C. et al. FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J. 26, 2104-2114 (2007).
14. Taniguchi, T. et al. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100, 2414-2420 (2002).
15. Matsushita, N. et al. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. Mol. Cell 19, 841-847 (2005).
16. Nijman, S.M. et al. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331-339 (2005).
17. Howlett, N.G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609 (2002).
18. Xia, B. et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell 22, 719-729 (2006).
19. Cantor, S.B. et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149-160 (2001).
20. Levitus, M. et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 103, 2498-2503 (2004).
21. Seki, S. et al. A requirement of FancL and FancD2 monoubiquitination in DNA repair. Genes Cells 12, 299-310 (2007).
22. Yamamoto, K. et al. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol. Cell. Biol. 25, 34-43 (2005).
23. Hirano, S. et al. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J. 24, 418-427 (2005).
24. Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160-1166 (2007).
25. Kinoshita, E., Kinoshita-Kikuta, E., Takiyama, K. & Koike, T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol. Cell. Proteomics 5, 749-757 (2006).
26. Zou, L. & Elledge, S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542-1548 (2003).
27. Sarkaria, J.N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375-4382 (1999).
28. Oestergaard, V.H. et al. Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell 28, 798-809 (2007).
29. West, S.C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 4, 435-445 (2003).
30. Ho, G.P., Margossian, S., Taniguchi, T. & D'Andrea, A.D. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol. Cell. Biol. 26, 7005-7015 (2006).
31. Wang, X. et al. Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway. Mol. Cell. Biol. 27, 3098-3108 (2007).
32. Meetei, A.R. et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37, 958-963 (2005).
33. Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28, 730-738 (2007).
34. Harper, J.W. & Elledge, S.J. The DNA damage response: ten years after. Mol. Cell 28, 739-745 (2007).
35. Yamamoto, K. et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23, 5421-5430 (2003).
36. Ishiai, M. et al. DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation. Mol. Cell. Biol. 24, 10733-10741 (2004).
37. Kitao, H. et al. Functional interplay between BRCA2/FANCD1 and FANCC in DNA repair. J. Biol. Chem. 281, 21312-21320 (2006).
38. Tomida, J., Kitao, H., Kinoshita, E. & Takata, M. Detection of phosphorylation on large proteins by western blotting using Phos-tag containing gel. Nat. Protocols doi:10.1038/nprot.2008.232 (in the press).